“Neutrophil Activation Marker CD15+ As a Prognostic Factor of Ocular Surface Damage in Type 2 Diabetics”. Ukrainian Journal of Ophthalmology , no. 1, Feb. 2024, pp. 15-19, https://doi.org/10.31288/oftalmolzh202411519.